Accéder au contenu
Merck

Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR).

Bioorganic & medicinal chemistry letters (2008-08-30)
Weixu Zhai, Neil Flynn, Daniel A Longhi, Joseph A Tino, Brian J Murphy, Dorothy Slusarchyk, David A Gordon, Anna Pendri, Shuhao Shi, Robert Stoffel, Baoqing Ma, Michael J Sofia, Samuel W Gerritz
RÉSUMÉ

The discovery and optimization of a novel series of prolinol-derived GHSR agonists is described. This series emerged from a 11,520-member solid-phase library targeting the GPCR protein superfamily, and the rapid optimization of low micromolar hits into single-digit nanomolar leads can be attributed to the solid-phase synthesis of matrix libraries, which revealed multiple non-additive structure-activity relationships. In addition, the separation of potent diastereomers highlighted the influence of the alpha-methyl stereochemistry of the phenoxyacetamide sidechain on GHSR activity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
(S)-(+)-2-Pyrrolidinemethanol, 97%